Search Results 381-390 of 10529 for cannabis
Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.
The purpose of this study is to determine distinct patterns of change in the quality of life and symptom burden in mRCC patients receiving therapy.
Note: urine drug screen positive for cannabis is exclusionary unless the Investigator and. Medical Monitor agree that the subject can abstain from use for ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Patients with previously untreated low tumor burden indolent Non-Hodgkin's Lymphoma (NHL) will receive either rituximab or GA101 weekly for 4 weeks followed by ...
Current smoker/vaper or current use of the following inhaled substances (e.g., tobacco or cannabis smoke, nicotine vapors). Individuals who have given up ...
Watch Mayo Clinic dermatologist Julia Lehman, M.D., describe how specialists work together to help people who develop skin changes following blood and ...
Rising trend of acute myocardial infarction among young cannabis users: A 10-year nationwide gender and race stratified analysis. Int J Cardiol Cardiovasc ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your Annual Fund gift can drive advancements in cancer care.